The industry engages in diverse and professional research, as is evident from the extent of academic publications in the field. It benefits from commercialization companies that operate in Israel, as can be seen by the number of patent applications that they submit.
Between 2005 and 2014, the number of life sciences companies in Israel grew significantly. Most life sciences companies (66%) were founded during that decade. Approximately 36% of the companies founded between 2011 and 2014 develop digital healthcare products.
Much of Israel’s financial success can be attributed to its ability to realize its technological and scientific potential. The activities in the various segments of the life sciences industry represent some 50% of the civilian research conducted at Israel’s seven universities, ten research centers, and five schools of medicine. Israel has one of the world’s highest concentrations of scientists per capita (145 for every 10,000 citizens), and one in three Israeli scientists specialize in some aspect of life sciences.
The number of publications in the life sciences industry is one of the parameters for academic excellence in the field. According to a study conducted by the Samuel Neaman Institute, 58,210 scientific articles were published in Israel between 2007 and 2011, 45% of which were related to life sciences. Specifically, 23% of the scientific publications were on clinical medicine.